Anirban Sengupta1, Sumeet Agarwal2, Pradeep Kumar Gupta3, Sunita Ahlawat4, Rana Patir5, Rakesh Kumar Gupta3, Anup Singh6. 1. Centre for Biomedical Engineering, IIT Delhi, New Delhi, India. 2. Department of Electrical Engineering, IIT Delhi, New Delhi, India. 3. Department of Radiology, Fortis Memorial Research Institute, Gurgaon, India. 4. SRL Diagnostics, Fortis Memorial Research Institute, Gurgaon, India. 5. Department of Neurosurgery, Fortis Memorial Research Institute, Gurgaon, India. 6. Centre for Biomedical Engineering, IIT Delhi, New Delhi, India; Department of Biomedical Engineering, AIIMS Delhi, New Delhi, India. Electronic address: anupsm@iitd.ac.in.
Abstract
PURPOSE: High grade gliomas (HGGs) are infiltrative in nature. Differentiation between vasogenic edema and non-contrast enhancing tumor is difficult as both appear hyperintense in T2-W/FLAIR images. Most studies involving differentiation between vasogenic edema and non-enhancing tumor consider radiologist-based tumor delineation as the ground truth. However, analysis by a radiologist can be subjective and there remain both inter- and intra-rater differences. The objective of the current study is to develop a methodology for differentiation between non-enhancing tumor and vasogenic edema in HGG patients based on T1 perfusion MRI parameters, using a ground truth which is independent of a radiologist's manual delineation of the tumor. MATERIAL AND METHODS: This study included 9 HGG patients with pre- and post-surgery MRI data and 9 metastasis patients with pre-surgery MRI data. MRI data included conventional T1-W, T2-W, and FLAIR images and DCE-MRI dynamic images. In this study, the authors hypothesize that surgeried non-enhancing FLAIR hyperintense tissue, which was obtained using pre- and post-surgery MRI images of glioma patients, should be largely comprised of non-enhancing tumor. Hence this could be used as an alternative ground truth for the non-enhancing tumor region. Histological examination of the resected tissue was done for validation. Vasogenic edema was obtained from the non-enhancing FLAIR hyperintense region of metastasis patients, as they have a clear boundary between enhancing tumor and edema. DCE-MRI data analysis was performed to obtain T1 perfusion MRI parameters. Support Vector Machine (SVM) classification was performed using T1 perfusion MRI parameters to differentiate between non-enhancing tumor and vasogenic edema. Receiver-operating-characteristic (ROC) analysis was done on the results of the SVM classifier. For improved classification accuracy, the SVM output was post-processed via neighborhood smoothing. RESULTS: Histology results showed that resected tissue consists largely of tumorous tissue with 7.21 ± 4.05% edema and a small amount of healthy tissue. SVM-based classification provided a misclassification error of 8.4% in differentiation between non-enhancing tumor and vasogenic edema, which was further reduced to 2.4% using neighborhood smoothing. CONCLUSION: The current study proposes a semiautomatic method for segmentation between non-enhancing tumor and vasogenic edema in HGG patients, based on an SVM classifier trained on an alternative ground truth to a radiologist's manual delineation of a tumor. The proposed methodology may prove to be a useful tool for pre- and post-operative evaluation of glioma patients.
PURPOSE: High grade gliomas (HGGs) are infiltrative in nature. Differentiation between vasogenic edema and non-contrast enhancing tumor is difficult as both appear hyperintense in T2-W/FLAIR images. Most studies involving differentiation between vasogenic edema and non-enhancing tumor consider radiologist-based tumor delineation as the ground truth. However, analysis by a radiologist can be subjective and there remain both inter- and intra-rater differences. The objective of the current study is to develop a methodology for differentiation between non-enhancing tumor and vasogenic edema in HGG patients based on T1 perfusion MRI parameters, using a ground truth which is independent of a radiologist's manual delineation of the tumor. MATERIAL AND METHODS: This study included 9 HGG patients with pre- and post-surgery MRI data and 9 metastasispatients with pre-surgery MRI data. MRI data included conventional T1-W, T2-W, and FLAIR images and DCE-MRI dynamic images. In this study, the authors hypothesize that surgeried non-enhancing FLAIR hyperintense tissue, which was obtained using pre- and post-surgery MRI images of gliomapatients, should be largely comprised of non-enhancing tumor. Hence this could be used as an alternative ground truth for the non-enhancing tumor region. Histological examination of the resected tissue was done for validation. Vasogenic edema was obtained from the non-enhancing FLAIR hyperintense region of metastasispatients, as they have a clear boundary between enhancing tumor and edema. DCE-MRI data analysis was performed to obtain T1 perfusion MRI parameters. Support Vector Machine (SVM) classification was performed using T1 perfusion MRI parameters to differentiate between non-enhancing tumor and vasogenic edema. Receiver-operating-characteristic (ROC) analysis was done on the results of the SVM classifier. For improved classification accuracy, the SVM output was post-processed via neighborhood smoothing. RESULTS: Histology results showed that resected tissue consists largely of tumorous tissue with 7.21 ± 4.05% edema and a small amount of healthy tissue. SVM-based classification provided a misclassification error of 8.4% in differentiation between non-enhancing tumor and vasogenic edema, which was further reduced to 2.4% using neighborhood smoothing. CONCLUSION: The current study proposes a semiautomatic method for segmentation between non-enhancing tumor and vasogenic edema in HGG patients, based on an SVM classifier trained on an alternative ground truth to a radiologist's manual delineation of a tumor. The proposed methodology may prove to be a useful tool for pre- and post-operative evaluation of gliomapatients.
Authors: Yae Won Park; Sung Soo Ahn; Ju Hyung Moon; Eui Hyun Kim; Seok-Gu Kang; Jong Hee Chang; Se Hoon Kim; Seung-Koo Lee Journal: Neuroradiology Date: 2021-03-23 Impact factor: 2.804